May 29, 2019 / 9:59 PM / 2 months ago

Drugmaker Almirall settles kickback allegations for $6.6 million

Spanish drugmaker Almirall has agreed to pay $6.6 million to resolve claims that its U.S. unit paid kickbacks to incentivize doctors to prescribe its dermatology products, the U.S. Justice Department and lawyers for a whistleblower said on Wednesday.

The settlements will resolve allegations first raised by a former sales representative who claimed the company used kickbacks to promote its drugs Monodox, Cordran and Acticlate in a whistleblower lawsuit filed in federal court in Philadelphia.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/30S3yca

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below